GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Syncom Formulation (India) Ltd (BOM:524470) » Definitions » Sale Of Investment

Syncom Formulation (India) (BOM:524470) Sale Of Investment : ₹0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Syncom Formulation (India) Sale Of Investment?

Syncom Formulation (India)'s sale of investment for the three months ended in Sep. 2024 was ₹0 Mil. It means Syncom Formulation (India) gained ₹0 Mil from selling investments. Syncom Formulation (India)'s sale of investment for the trailing twelve months (TTM) ended in Sep. 2024 was ₹0 Mil.

Compared with last quarter (₹0 Mil in Jun. 2024 ), Syncom Formulation (India) gained the same money from selling investments in Sep. 2024 (₹0 Mil).


Syncom Formulation (India) Sale Of Investment Historical Data

The historical data trend for Syncom Formulation (India)'s Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syncom Formulation (India) Sale Of Investment Chart

Syncom Formulation (India) Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Syncom Formulation (India) Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Syncom Formulation (India) Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Syncom Formulation (India) Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Syncom Formulation (India)'s Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Syncom Formulation (India) Business Description

Traded in Other Exchanges
Address
207, Saket Nagar, Near Saket Club, Indore, MP, IND, 452018
Syncom Formulation (India) Ltd is in the business of pharmaceuticals. The company operates through three segments including manufacturing and dealings in Pharmaceutical drugs and formulations, Trading of commodities, and Renting of property. It manufactures and markets pharmaceutical formulation products in various dosage forms like tablets, capsules, liquids orals, liquids vials, ampoule injections and dry vial injections, dry syrups, ointments, inhalers, and Herbals. The company's product includes generic, antiviral, antidepressant, cough suppressant, electrolyte, histamine, estrogen, and much more. It generates maximum revenue through the Pharmaceutical drugs and formulations segment.

Syncom Formulation (India) Headlines

No Headlines